[1] World Health Organization. Global tuberculosis control:WHO report 2011.WHO/HTM/TB/2011.16. Geneva:World Health Orgnization,2011.
[2] Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effective tuberculosis vaccines,drugs,and diagnostics.Proc Natl Acad Sci U S A,2009,106(33):13980-13985.
[3] Joshi R, Reingold AL, Menzies D, et al. Tuberculosis among health-care workers in low-and middle-income countries: a systematic review. PLoS Med,2006,3(12):e494.
[4] Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis,2007,11(6):593-605.
[5] Diel R, Seidler A, Nienhaus A, et al. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res,2005,6(1):35.
[6] Girardi E, Angeletti C, Puro V, et al. Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveill,2009,14(43).pii:19373.
[7] Tissot F, Zanetti G, Francioli P, et al. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis,2005,40(2):211-217.
[8] Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med,1999,159(1):15-21.
[9] Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet,2000,356(9235):1099-1104.
[10] 刘旭辉,肖和平. γ-干扰素释放试验(IGRA)对于结核分枝杆菌感染的应用. 临床肺科杂志,2009,14(5):672-674.
[11] Casas I, Latorre I, Esteve M, et al. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One,2009,4(8):e6686.
[12] Yotsumoto H. Specific immune-based diagnosis of tuberculosis infection. Rinsho Byori[Japanese],2008, 56(11):1026-1033.
[13] Zwerling A, van den Hof S, Scholten J, et al. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax,2012,67(1):62-70.
[14] Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J RespirCrit Care Med,2004,170(3):288-295.
[15] Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis,2004,38(7):966-973.
[16] Jensen PA,Lambert LA,Iademarco MF,et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings,2005.MMWR Recomm Rep,2005,54(RR-17):1-141.
[17] Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).Can Commun Dis Rep,2008,34(ACS-6):1-13.
[18] National Tuberculosis Advisory Committe.Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection, October 2007. Commun Dis Intell,2007,31(4):404-405.
[19] National Institute for Health and Clinical Excellence(NICE).Tuberculosis:cinical diagnosis and management of tuverculosis,and measures for its prevention and control.Clinical guideline 33.London:NICE,2006.
[20] Song Q, Guo H, Zhong H, et al. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak. Int J Infect Dis,2012, 16(7):e522-526.
[21] Herrera V, Perry S, Parsonnet J, et al. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis,2011,52(8):1031-1037.
[22] Abdalhamid B, Hinrichs SH, Garrett JL, et al. Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. J Clin Microbiol,2010,48(8):2955-2956.
[23] Fox BD, Kramer MR, Mor Z, et al. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis. Lung,2009,187(6):413-419.
[24] Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med,2010,10:7.
[25] Tsiouris SJ, Coetzee D, Toro PL,et al. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol, 2006,44(8):2844-2850.
[26] Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med,2007,146(5):340-354.
[27] Baussano I, Nunn P, Williams B, et al. Tuberculosis among health care workers. Emerg Infect Dis,2011,17(3):488-494.
[28] Soborg B, Andersen AB, Larsen HK, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis,2007,39(6/7):554-559.
[29] Ozdemir D, Annakkaya AN, Tarhan G, et al. Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey. Jpn J Infect Dis,2007,60(2/3):102-105.
[30] Casas I, Esteve M, Guerola R,et al. A study of tuberculosis infection in workers at a university general hospital: associated factors and evolution in 20 years. Arch Bronconeumol,2011,47(11):541-546.
[31] Schablon A, Harling M, Diel R, et al. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis,2010,10:107.
[32] Harada N, Nakajima Y, Higuchi K, et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol,2006,27(5):442-448.
[33] Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA,2005,293(22):2746-2755.
[34] Rafiza S, Rampal KG, Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect Dis,2011,11:19.
[35] Mirtskhulava V, Kempker R, Shields KL, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis,2008,12(5):513-519.
[36] 张忠顺,楼海,肖和平. 结核病专业人员及密切接触者结核潜伏感染的研究. 中国防痨杂志,2011,32(01):44-48.
[37] Talebi-Taher M, Javad-Moosavi SA, Entezari AH, et al. Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers. Int J Occup Med Environ Health,2011,24(4):359-366.
[38] Demkow U, Broniarek-Samson B, Filewska M, et al. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests. J Physiol Pharmacol,2008,59 Suppl 6:209-217.
[39] Drobniewski F, Balabanova Y, Zakamova E, et al. Rates of latent tuberculosis in health care staff in Russia. PLoS Med,2007,4(2):e55.
[40] 彭远珍.结核病房空气微生物密度研究.临床医药实践,2008,17(3):185-187.
[41] 张秀峰,赵辉,徐惠泉,等.结核病房使用前后空气细菌含量对比研究.中华医院感染学杂志,2009,19(15):1986-1987
[42] Franchi A, Richeldi L, Parrinello G, et al. Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient.Int Arch Occup Environ Health,2007,80(6):533-538. |
京公安网备11010202008787号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
